EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The Choice between Intravenous and Subcutaneous Immunoglobulins: Aspects for Consideration

Caroline von Achenbach, Giselle Hevia Hernandez, Stephan von Gunten

Pharmacology · 2022 · 107 (11-12) · 556-563

DOI: 10.1159/000527655 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmacology, online erschienen am 08.11.2022. Verfasst von Caroline von Achenbach und 2 weiteren Autor:innen. Beteiligte Einrichtung: CSL Behring AG, Bern, Switzerland. Hauptthemen laut MEDLINE: Immunoglobulins, Immunologic Deficiency Syndromes. Die Arbeit wurde bisher 10-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: Intravenous immunoglobulin and subcutaneous immunoglobulin preparations are used to treat primary and secondary immunodeficiencies, as well as autoimmune and inflammatory conditions. Summary: For certain indications, only defined formulations or routes of administration are approved by health authorities. However, for other diseases, there are more options, and treatment decisions may be based on different aspects, such as patient conditions and preferences, pharmacokinetics, or pharmacoeconomic considerations. Key Messages: Understanding the two different treatment modalities may support the decision-making for the optimal therapeutic option for individual patients. This review summarizes the latest insights into the direct and indirect comparison between the two types of products.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunoglobulinsImmunologic Deficiency SyndromesHumansImmunoglobulins, IntravenousAdministration, Intravenous

Stichwörter der Autor:innen

AutoimmunityImmunodeficiencyIntravenous immunoglobulinSubcutaneous immunoglobulin

Substanzen

ImmunoglobulinsImmunoglobulins, Intravenous

Autor:innen und Institutionen

  • CSL Behring AG, Bern, Switzerland.
  • Institute of Pharmacology, University of Bern, Bern, Switzerland.
  • Bern Center for Precision Medicine (BCPM), University of Bern, Bern, Switzerland.

Zitieren

APA

von Achenbach, C., Hevia Hernandez, G., & von Gunten, S. (2022). The Choice between Intravenous and Subcutaneous Immunoglobulins: Aspects for Consideration. Pharmacology, 107(11-12), 556-563. https://doi.org/10.1159/000527655

Vancouver

von Achenbach C, Hevia Hernandez G, von Gunten S. The Choice between Intravenous and Subcutaneous Immunoglobulins: Aspects for Consideration. Pharmacology. 2022;107(11-12):556-563. doi:10.1159/000527655

BibTeX
@article{vonAchenbach2022,
  author = {von Achenbach, Caroline and Hevia Hernandez, Giselle and von Gunten, Stephan},
  title = {The Choice between Intravenous and Subcutaneous Immunoglobulins: Aspects for Consideration},
  journal = {Pharmacology},
  year = {2022},
  volume = {107},
  number = {11-12},
  pages = {556--563},
  doi = {10.1159/000527655}
}
Kostenlos starten →